Prohibits the sale of intravenous solution containers and intravenous tubing products intentionally made with DEHP

HB 3357 prohibits the sale of intravenous (IV) solution containers and IV tubing products that intentionally contain DEHP, a chemical additive. It directly affects medical device manufacturers and distributors in Missouri, banning sales of DEHP-containing IV containers starting January 1, 2030, and IV tubing starting January 1, 2035. The bill also bans replacing DEHP with other similar chemicals (orthophthalates) and limits unintentional DEHP to 0.1% weight per weight. Exemptions include blood collection bags and certain apheresis kits. The law aims to reduce exposure to DEHP in medical settings where it is used in IV products for patient care.